Chris M. Calcaterra
Net Worth

Last updated:

What is Chris M. Calcaterra net worth?

The estimated net worth of Mr. Chris M. Calcaterra is at least $34,257,626 as of 1 Feb 2021. He owns shares worth $14,578,734 as insider, has earned $14,701,172 from insider trading and has received compensation worth at least $4,977,720 in Glaukos Corporation.

What is the salary of Chris M. Calcaterra?

Mr. Chris M. Calcaterra salary is $553,080 per year as Chief Operating Officer in Glaukos Corporation.

How old is Chris M. Calcaterra?

Mr. Chris M. Calcaterra is 65 years old, born in 1960.

What stocks does Chris M. Calcaterra currently own?

As insider, Mr. Chris M. Calcaterra owns shares in one company:

Company Title Shares Price per share Total value
Glaukos Corporation (GKOS) Chief Operating Officer 163,806 $89 $14,578,734

What does Glaukos Corporation do?

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, a three stents product that is designed for use as a standalone procedure in patients with refractory glaucoma; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in San Clemente, California.

GKOS logo
GKOS
Glaukos Corporation
$89

Chris M. Calcaterra insider trading

Glaukos Corporation

Mr. Chris M. Calcaterra has made 18 insider trades between 2016-2021, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 73,396 units of GKOS stock on 5 Mar 2019. As of 1 Feb 2021 he still owns at least 163,806 units of GKOS stock.

Transaction Date Security Shares Price per share Total value Source
Option
Stock Options (Right to Buy) 60,417 $16.49 $996,276
Sale
Common Stock 60,417 $44.02 $2,659,738
Option
Common Stock 60,417 $16.49 $996,276
Sale
Common Stock 60,417 $88.15 $5,326,000
Sale
Common Stock 60,417 $88.15 $5,326,000
Sale
Common Stock 16,604 N/A N/A
Sale
Common Stock 73,396 N/A N/A
Option
Stock Options (Right to buy) 38,983 N/A N/A
Option
Common Stock 38,983 N/A N/A
Sale
Common Stock 38,983 N/A N/A
Sale
Common Stock 2,470 N/A N/A
Option
Stock Options (Right to buy) 600 N/A N/A
Option
Common Stock 2,470 N/A N/A
Option
Stock Option (Right to buy) 1,870 N/A N/A
Option
Stock Options (Right to buy) 7,759 N/A N/A
Sale
Common Stock 7,759 N/A N/A
Option
Common Stock 7,759 N/A N/A
Option
Stock Options (Right to buy) 8,771 N/A N/A
Option
Common Stock 8,771 N/A N/A
Sale
Common Stock 8,771 N/A N/A
Option
Common Stock 3,723 N/A N/A
Sale
Common Stock 3,723 N/A N/A
Option
Stock Options (Right to buy) 3,723 N/A N/A
Option
Stock Options (Right to buy) 14,413 N/A N/A
Option
Common Stock 14,413 N/A N/A
Sale
Common Stock 14,413 N/A N/A
Sale
Common Stock 20,000 N/A N/A
Option
Stock Options (Right to buy) 20,000 N/A N/A
Option
Common Stock 20,000 N/A N/A
Sale
Common Stock 20,000 N/A N/A
Option
Common Stock 20,000 N/A N/A
Option
Stock Options (Right to buy) 20,000 N/A N/A
Sale
Common Stock 40,000 N/A N/A
Option
Common Stock 40,000 N/A N/A
Option
Stock Options (Right to buy) 40,000 N/A N/A
Option
Stock Options (Right to buy) 45,464 $5.75 $261,418
Sale
Common Stock 45,464 N/A N/A
Option
Stock Options (Right to buy) 45,464 N/A N/A
Option
Common Stock 45,464 N/A N/A
Option
Common Stock 45,464 $5.75 $261,418
Sale
Common Stock 56,951 $24.4 $1,389,434
Option
Common Stock 68,000 N/A N/A
Sale
Common Stock 56,951 N/A N/A
Option
Stock Options (Right to buy) 68,000 N/A N/A
Sale
Common Stock 700 N/A N/A

Glaukos key executives

Glaukos Corporation executives and other stock owners filed with the SEC: